RE: Beckman Coulter is huge3 Feb 2021 09:13
GDR Valuation of COVID Tests:
Extract from my post on 12th Sept: - GDR Potential: - 'And Now since BC/GDR Agreement, it is Even Better !
I believe that GDR Mcap is potentially worth £300 mil Mcap, based on projected Sales and Profit.
I expect GDR to sell 50,000 RT-PCR Test units/day at £10 per Test = £500,000 per day revenue at 60% profit margin = £300,000 per day profit.
Working on a 5 day week = 5 x £300,000 = £1,500,000 profit per week.
£1,500,000 x 50 wks per year = £75,000,000 profit per year.
Using a standard multiple of 4 for valuation = 4 x £75,000,000 = Mcap of £300,000,000
Mcap of £300,000,000 divided by 52,000,000 shares = a potential SP of £5.77p
This Mcap valuation did not take into consideration a valuation of our POC; HCV OR AIHL etc
I need to change my calculation now, due to increase in GDR Total Shares in market:
Therefore - £300,000,000 divided by 56,464,752 shares = a potential £5.31 SP !
However:-
Taking into consideration BGF conversion of their Loan Note to Shares, means our Total Share in Market will rise to 64,000,000 Shares.
Therefore - £300,000,000 divided by 64,000,000 shares = a potential £4.68p SP !